agilon health, inc.

NYSE:AGL Stock Report

Market Cap: US$782.8m

agilon health Future Growth

Future criteria checks 1/6

agilon health is forecast to grow earnings and revenue by 55% and 13.2% per annum respectively. EPS is expected to grow by 55.4% per annum. Return on equity is forecast to be -23% in 3 years.

Key information

55.0%

Earnings growth rate

55.4%

EPS growth rate

Healthcare earnings growth18.9%
Revenue growth rate13.2%
Future return on equity-23.0%
Analyst coverage

Good

Last updated20 Dec 2024

Recent future growth updates

Recent updates

agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Nov 10
agilon health, inc. (NYSE:AGL) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny

agilon health Plunges On A Poor Prognosis (Rating Downgrade)

Nov 08

Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

Oct 15
Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

agilon health: Interesting Business Model, But Volatile And Uncertain

Aug 16

Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower

Aug 16
Market Cool On agilon health, inc.'s (NYSE:AGL) Revenues Pushing Shares 34% Lower

Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

Jul 15
Rock star Growth Puts agilon health (NYSE:AGL) In A Position To Use Debt

The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More

Jun 06
The Market Lifts agilon health, inc. (NYSE:AGL) Shares 41% But It Can Do More

agilon health: Still Not Healthy Enough To Warrant Upside

Apr 19

Is agilon health (NYSE:AGL) Using Too Much Debt?

Apr 04
Is agilon health (NYSE:AGL) Using Too Much Debt?

agilon health: High Growth But Unsustainable Economics

Nov 20

agilon health: Strong Sales Growth, Lacks Remaining Value Drivers

Sep 13

Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

Jul 17
Market Participants Recognise agilon health, inc.'s (NYSE:AGL) Revenues

agilon health: A Hold Until Margins Are Improved

Jun 30

An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Jun 06
An Intrinsic Calculation For agilon health, inc. (NYSE:AGL) Suggests It's 35% Undervalued

Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

Apr 28
Is It Time To Consider Buying agilon health, inc. (NYSE:AGL)?

Earnings and Revenue Growth Forecasts

NYSE:AGL - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20279,122-38-2084
12/31/20267,716-101-271215
12/31/20256,651-167-77-4119
12/31/20246,055-237-198-12319
9/30/20245,594-311-180-135N/A
6/30/20245,280-217-186-141N/A
3/31/20244,866-202-185-143N/A
12/31/20234,316-195-187-156N/A
9/30/20233,630-69-169-145N/A
6/30/20233,188-78-151-129N/A
3/31/20232,789-83-200-168N/A
12/31/20222,388-92-163-131N/A
9/30/20222,481-108-158-130N/A
6/30/20222,245-114-181-152N/A
3/31/20222,074-391-145-131N/A
12/31/20211,521-384-162-148N/A
9/30/20211,692-387-123-113N/A
6/30/20211,546-363-104-98N/A
3/31/20211,340-69-74-68N/A
12/31/20201,218-63-56-53N/A
9/30/20201,095-59-71-68N/A
12/31/2019794-114-108-104N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AGL is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AGL is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AGL is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AGL's revenue (13.2% per year) is forecast to grow faster than the US market (9% per year).

High Growth Revenue: AGL's revenue (13.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: AGL is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 11:58
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

agilon health, inc. is covered by 29 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hua HaBaird
Andrew MokBarclays
William SutherlandBenchmark Company